PSP Research »

Definium Therape shares owned by PSP Research

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $658k 35k 18.90

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Definium Therape

Driehaus Capital Management
Marshall Wace
AWM Investment Company
Ensign Peak Advisors
Kestra Private Wealth Services
PSP Research
Dark Forest Capital Management
Bay Rivers Group
Twelve Points Wealth Management
SG Americas Securities
Sound Income Strategies
Gf Fund Management
GAMMA Investing
Opal Wealth Advisors
Massmutual Trust

View all funds holding Definium Therape